{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:56:30Z","timestamp":1773672990113,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013301","name":"Parkinson's Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K02NS080915"],"award-info":[{"award-number":["K02NS080915"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR000040"],"award-info":[{"award-number":["UL1 TR000040"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["UL1 RR024156"],"award-info":[{"award-number":["UL1 RR024156"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001405","name":"Brookdale Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ymgme.2017.10.011","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T18:43:14Z","timestamp":1508784194000},"page":"135-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tandem mass spectrometry assay of \u03b2-glucocerebrosidase activity in dried blood spots eliminates false positives detected in fluorescence assay"],"prefix":"10.1016","volume":"123","author":[{"given":"Pavlina","family":"Wolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy N.","family":"Alcalay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Liong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmaline","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Pauciulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziv","family":"Gan-Or","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Faulkner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Bentis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Pomponio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Kate Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan M.","family":"Keutzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2017.10.011_bb0005","series-title":"Beta-glucosidase","author":"Beutler","year":"1990"},{"issue":"7","key":"10.1016\/j.ymgme.2017.10.011_bb0010","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease","volume":"45","author":"Brady","year":"1966","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2017.10.011_bb0015","series-title":"Gaucher Disease: Phenotypic and Genetic Variation, in The Online Metabolic and Molecular Bases of Inherited Disease","author":"Grabowski","year":"2014"},{"issue":"3","key":"10.1016\/j.ymgme.2017.10.011_bb0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ymgme.2017.10.011_bb0025","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archinternmed.2007.128","article-title":"Prevalence of type 1 Gaucher disease in the United States","volume":"168","author":"Weinreb","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgme.2017.10.011_bb0030","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Gaucher disease","year":"2014"},{"issue":"17","key":"10.1016\/j.ymgme.2017.10.011_bb0035","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-12-758409","article-title":"Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy","volume":"129","author":"Cox","year":"2017","journal-title":"Blood"},{"issue":"9985","key":"10.1016\/j.ymgme.2017.10.011_bb0040","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/S0140-6736(14)61841-9","article-title":"Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial","volume":"385","author":"Cox","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2017.10.011_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2014.04.002","article-title":"Eliglustat, an investigational oral therapy for Gaucher disease type 1: phase 2 trial results after 4years of treatment","author":"Lukina","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2017.10.011_bb0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcmd.2010.10.011","article-title":"Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults","volume":"46","author":"Mistry","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2017.10.011_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ymgmr.2016.08.009","article-title":"Stability is maintained in adults with Gaucher disease type 1 switched from velaglucerase alfa to eliglustat or imiglucerase: a sub-analysis of the eliglustat ENCORE trial","volume":"9","author":"Pleat","year":"2016","journal-title":"Mol Genet Metab Rep"},{"issue":"5","key":"10.1016\/j.ymgme.2017.10.011_bb0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1399-0004.2008.00978.x","article-title":"Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study","volume":"73","author":"Sims","year":"2008","journal-title":"Clin. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2017.10.011_bb0065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10545-012-9528-4","article-title":"Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment","volume":"36","author":"Weinreb","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2017.10.011_bb0070","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2017.10.011_bb0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a \u201csimple\u201d disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2017.10.011_bb0080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajh.21888","article-title":"A reappraisal of Gaucher disease-diagnosis and disease management algorithms","volume":"86","author":"Mistry","year":"2011","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.ymgme.2017.10.011_bb0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejim.2013.09.006","article-title":"Gaucher disease: a diagnostic challenge for internists","volume":"25","author":"Cassinerio","year":"2014","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ymgme.2017.10.011_bb0090","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-60761-459-3_32","article-title":"Multiplex lysosomal enzyme activity assay on dried blood spots using tandem mass spectrometry","volume":"603","author":"Zhang","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.ymgme.2017.10.011_bb0095","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1373\/clinchem.2004.035907","article-title":"Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening","volume":"50","author":"Li","year":"2004","journal-title":"Clin. Chem."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2017.10.011_bb0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cca.2008.08.024","article-title":"An improved high-throughput dried blood spot screening method for Gaucher disease","volume":"398","author":"Olivova","year":"2008","journal-title":"Clin. Chim. Acta"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2017.10.011_bb0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0009-8981(01)00798-7","article-title":"Gaucher and Niemann-Pick diseases\u2014enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards","volume":"317","author":"Chamoles","year":"2002","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"10.1016\/j.ymgme.2017.10.011_bb0110","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.bbalip.2013.06.001","article-title":"New insights on glucosylated lipids: metabolism and functions","volume":"1831","author":"Ishibashi","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"13\u201314","key":"10.1016\/j.ymgme.2017.10.011_bb0115","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cca.2011.03.012","article-title":"The effect of preparation, storage and shipping of dried blood spots on the activity of five lysosomal enzymes","volume":"412","author":"Elbin","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"Pt 9","key":"10.1016\/j.ymgme.2017.10.011_bb0120","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/brain\/awv179","article-title":"Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations","volume":"138","author":"Alcalay","year":"2015","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ymgme.2017.10.011_bb0125","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/jamaneurol.2014.313","article-title":"Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes","volume":"71","author":"Alcalay","year":"2014","journal-title":"JAMA Neurol."},{"issue":"14","key":"10.1016\/j.ymgme.2017.10.011_bb0130","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/mds.25647","article-title":"Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations","volume":"28","author":"Alcalay","year":"2013","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.ymgme.2017.10.011_bb0135","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS recommendations for the description of sequence variants: 2016 update","volume":"37","author":"den Dunnen","year":"2016","journal-title":"Hum. Mutat."},{"issue":"3\u20134","key":"10.1016\/j.ymgme.2017.10.011_bb0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cca.2010.11.013","article-title":"Characterization of the c.(\u2212203)A>G variant in the glucocerebrosidase gene and its association with phenotype in Gaucher disease","volume":"412","author":"Alfonso","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.ymgme.2017.10.011_bb0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1006\/bcmd.2000.0317","article-title":"A new gene-pseudogene fusion allele due to a recombination in intron 2 of the glucocerebrosidase gene causes Gaucher disease","volume":"26","author":"Cormand","year":"2000","journal-title":"Blood Cells Mol. Dis."},{"issue":"7","key":"10.1016\/j.ymgme.2017.10.011_bb0150","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1373\/clinchem.2016.269027","article-title":"Mass spectrometry but not Fluorimetry distinguishes affected and Pseudodeficiency patients in newborn screening for Pompe disease","volume":"63","author":"Liao","year":"2017","journal-title":"Clin. Chem."},{"issue":"Supplement C","key":"10.1016\/j.ymgme.2017.10.011_bb0155","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ymgmr.2017.04.009","article-title":"Misinformation regarding tandem mass spectrometric vs fluorometric assays to screen newborns for LSDs","volume":"11","author":"Millington","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2017.10.011_bb0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ymgmr.2017.05.004","article-title":"Comparison of tandem mass spectrometry to fluorimetry for newborn screening of LSDs","volume":"12","author":"Gelb","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"13\u201314","key":"10.1016\/j.ymgme.2017.10.011_bb0165","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.clinbiochem.2014.06.005","article-title":"Validity of beta-d-glucosidase activity measured in dried blood samples for detection of potential Gaucher disease patients","volume":"47","author":"Stroppiano","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2017.10.011_bb0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cca.2014.01.030","article-title":"Detecting multiple lysosomal storage diseases by tandem mass spectrometry - a national newborn screening program in Taiwan","volume":"431c","author":"Liao","year":"2014","journal-title":"Clin. Chim. Acta"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217305413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217305413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T15:34:08Z","timestamp":1535297648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719217305413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1096719217305413"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.10.011","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tandem mass spectrometry assay of \u03b2-glucocerebrosidase activity in dried blood spots eliminates false positives detected in fluorescence assay","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}